ADAR1 CAPITAL MANAGEMENT, LLC purchased 11.4% of their position (91.10K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $118.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/16/2026ACC: 0001940272-26-000021
10% Owner
Since May 2026
+91.10K
Net shares
Net buyer
$118.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
91.10K acquired
Non-Derivative Transactions3
Common Shares
Indirect
Shares
+28.50K
Price / share
$1.29
Trade value
$36.88K
% of position
3.6%
9/14/2026
801K→829.50K
Common Shares
Indirect
Shares
+54.26K
Price / share
$1.30
Trade value
$70.45K
% of position
6.5%
9/15/2026
829.50K→883.76K
Common Shares
Indirect
Shares
+8.34K
Price / share
$1.29
Trade value
$10.75K
% of position
0.9%
9/16/2026
883.76K→892.10K
Total
Net shares
+91.10K
Net value
$118.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 9/14/2026 | P · Purchase | +28.50K | $1.29 | $36.88K | 3.6% | 801K | 829.50K |
| Common Shares Indirect | 9/15/2026 | P · Purchase | +54.26K | $1.30 | $70.45K | 6.5% | 829.50K | 883.76K |
| Common Shares Indirect | 9/16/2026 | P · Purchase | +8.34K | $1.29 | $10.75K | 0.9% | 883.76K | 892.10K |
| Total | +91.10K | $118.08K | ||||||
Derivative Transactions0
No derivative transactions reported